Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD

Conclusion: Enose technology is able to classify newly presented patients with a differential diagnosis of asthma or COPD with high accuracy into their classic diagnostic labels and clinical/inflammatory phenotypes. These data validate breathomics for stratification of patients with chronic airway diseases in the doctor’s office.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: de Vries, R., Dagelet, Y. W. F., Kester, S., In 'T Veen, J. H. H. C., Haarman, E. G., Lucas, A., De Jongh, F. H. C., Maitland-Van Der Zee, A.-H., Sterk, P. J. Tags: Monitoring Airway Disease Source Type: research